BRPI0409767A - processo para a obtenção de guggulsterona e guggulsterol - Google Patents

processo para a obtenção de guggulsterona e guggulsterol

Info

Publication number: BRPI0409767A
Authority: BR; Brazil
Prior art keywords: guggulsterone; formula; guggulsterol; obtaining; pregnadiene
Prior art date: 2003-04-24

Application number

BRPI0409767-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Heonjoong Kang

Original Assignee

Heonjoong Kang

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2004-04-24

Publication date

2006-05-30

2003-04-24 Priority claimed from KR1020030025989A external-priority patent/KR100543547B1/ko

2003-04-24 Priority claimed from KR1020030025904A external-priority patent/KR100639655B1/ko

2003-04-24 Priority claimed from KR1020030025936A external-priority patent/KR100543542B1/ko

2003-04-24 Priority claimed from KR1020030025962A external-priority patent/KR100543544B1/ko

2003-04-24 Priority claimed from KR1020030025919A external-priority patent/KR100543533B1/ko

2004-04-24 Application filed by Heonjoong Kang filed Critical Heonjoong Kang

2006-05-30 Publication of BRPI0409767A publication Critical patent/BRPI0409767A/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C07J33/007—Cyclic thioketals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BRPI0409767-0A 2003-04-24 2004-04-24 processo para a obtenção de guggulsterona e guggulsterol BRPI0409767A (pt)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
KR1020030025989A KR100543547B1 (ko)	2003-04-24	2003-04-24	프로제스테론으로부터 구굴스테론의 제조방법 및 이를제조하기 위한 중간체
KR1020030025904A KR100639655B1 (ko)	2003-04-24	2003-04-24	16α,17α-에폭시프레그네놀론으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체
KR1020030025936A KR100543542B1 (ko)	2003-04-24	2003-04-24	4-안드로스텐-3,17-디온으로부터 구굴스테론의 제조방법및 이를 제조하기 위한 중간체
KR1020030025962A KR100543544B1 (ko)	2003-04-24	2003-04-24	테스토스테론으로부터 구굴스테론의 제조방법 및 이를제조하기 위한 중간체
KR1020030025919A KR100543533B1 (ko)	2003-04-24	2003-04-24	5-안드로스텐-3β-올-17-온으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체
PCT/KR2004/000950 WO2004094450A1 (en)	2003-04-24	2004-04-24	Process for preparing guggulsterones and guggulsterol

Publications (1)

Publication Number	Publication Date
BRPI0409767A true BRPI0409767A (pt)	2006-05-30

Family

ID=36479563

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0409767-0A BRPI0409767A (pt)	2003-04-24	2004-04-24	processo para a obtenção de guggulsterona e guggulsterol

Country Status (9)

Country	Link
US (1)	US20070055072A1 (de)
EP (4)	EP2594577A1 (de)
JP (2)	JP4895804B2 (de)
AT (1)	ATE535538T1 (de)
AU (1)	AU2004232615B2 (de)
BR (1)	BRPI0409767A (de)
CA (1)	CA2523369C (de)
ES (1)	ES2376549T3 (de)
WO (1)	WO2004094450A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0409767A (pt) *	2003-04-24	2006-05-30	Heonjoong Kang	processo para a obtenção de guggulsterona e guggulsterol
EP1886685A1 (de)	2006-08-11	2008-02-13	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methoden, Verwendungen und Zusammensetzungen zur Modulation der Replikation von HCV durch Aktivierung oder Hemmung des Farnesoid X Rezeptors
JP2010509355A (ja) *	2006-11-06	2010-03-25	ジャイナファーマシューティカルズ，インコーポレーテッド	グッグルリン脂質の方法および組成物
CN101195648A (zh) *	2007-12-03	2008-06-11	邵阳市科瑞化学品有限公司	制备二烯甾酮的方法
CN113082960B (zh) *	2021-04-09	2022-05-20	辽宁科技大学	一种宽温度窗口烟气脱硫用低共熔溶剂及生产、再生方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3141028A (en) *	1962-10-02	1964-07-14	Searle & Co	16-oxygenated pregna-4, 17(20)-[trans] dien-3-ones and intermediates thereto
EP0447706A1 (de) *	1990-03-22	1991-09-25	Cipla Limited	Verfahren zur Herstellung einer pharmazeutischen aktiven Mischung der Guggulsteronen Z und E
DE4313089A1 (de) *	1993-04-22	1994-10-27	Basf Ag	Verfahren zur Herstellung von 13-(Z)-Retinsäure
KR100446068B1 (ko) *	2001-10-23	2004-08-30	동방에프티엘 주식회사	구굴스테론의 제조방법
WO2004021975A2 (en) *	2002-09-03	2004-03-18	Ganga Raju Gokaraju	An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones
BRPI0409767A (pt) *	2003-04-24	2006-05-30	Heonjoong Kang	processo para a obtenção de guggulsterona e guggulsterol

2004
- 2004-04-24 BR BRPI0409767-0A patent/BRPI0409767A/pt not_active IP Right Cessation
- 2004-04-24 ES ES04729374T patent/ES2376549T3/es not_active Expired - Lifetime
- 2004-04-24 AU AU2004232615A patent/AU2004232615B2/en not_active Ceased
- 2004-04-24 EP EP13153819.1A patent/EP2594577A1/de not_active Withdrawn
- 2004-04-24 EP EP10168885A patent/EP2284176A1/de not_active Withdrawn
- 2004-04-24 AT AT04729374T patent/ATE535538T1/de active
- 2004-04-24 US US10/554,439 patent/US20070055072A1/en not_active Abandoned
- 2004-04-24 WO PCT/KR2004/000950 patent/WO2004094450A1/en not_active Ceased
- 2004-04-24 EP EP04729374A patent/EP1620455B1/de not_active Expired - Lifetime
- 2004-04-24 JP JP2006507820A patent/JP4895804B2/ja not_active Expired - Fee Related
- 2004-04-24 EP EP10168887A patent/EP2251346A3/de not_active Withdrawn
- 2004-04-24 CA CA002523369A patent/CA2523369C/en not_active Expired - Fee Related
2011
- 2011-04-05 JP JP2011083955A patent/JP5430603B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP2594577A1 (de)	2013-05-22
ATE535538T1 (de)	2011-12-15
EP1620455B1 (de)	2011-11-30
EP2251346A3 (de)	2011-02-16
AU2004232615B2 (en)	2007-05-24
US20070055072A1 (en)	2007-03-08
EP2284176A1 (de)	2011-02-16
AU2004232615A1 (en)	2004-11-04
CA2523369C (en)	2009-08-04
WO2004094450A1 (en)	2004-11-04
EP1620455A4 (de)	2009-08-05
CA2523369A1 (en)	2004-11-04
EP1620455A1 (de)	2006-02-01
JP2006524237A (ja)	2006-10-26
JP4895804B2 (ja)	2012-03-14
JP2011157382A (ja)	2011-08-18
EP2251346A2 (de)	2010-11-17
JP5430603B2 (ja)	2014-03-05
ES2376549T3 (es)	2012-03-14

Similar Documents

Publication	Publication Date	Title
ZA200107598B (en)	2003-05-28	Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol.
WO2001077072A3 (en)	2002-07-18	Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
PE20030868A1 (es)	2003-10-21	Derivados de nicotinamida utiles como inhibidores de pde4
WO2002087556A3 (en)	2003-02-06	Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
EE200300136A (et)	2003-08-15	Kompositsioonid ja meetodid lipoproteiin (a) taseme alandamiseks plasmas ja kardiovaskulaarsete haiguste riskifaktorite vähendamiseks
AU8016200A (en)	2001-04-23	Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
WO2002020501A3 (en)	2002-06-27	Polyarylcarboxamides useful as lipid lowering agents
MXPA03007734A (es)	2003-12-04	Metodo para la busqueda de una guia de programas electronica.
WO2007027532A3 (en)	2009-06-18	Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2005030120A3 (en)	2005-12-15	Antiangiogenic agents
TNSN08153A1 (en)	2009-10-30	Anti-hypercholesterolemic compounds
WO2001072335A3 (en)	2002-08-01	Methods for effecting neuroprotection using a potassium channel modulator
BRPI0409767A (pt)	2006-05-30	processo para a obtenção de guggulsterona e guggulsterol
NO20071510L (no)	2007-06-11	4-Amino-substituerte-2-substituerte-1,2,3,4-tetrahydrokinolinforbindelser
TW200606581A (en)	2006-02-16	A chemically amplified positive resist composition, a haloester derivative and a process for producing the same
DE60306667D1 (de)	2006-08-17	Cefdinir salze als zwischenprodukte
WO2005096704A3 (en)	2006-04-06	Cholesterol lowering composition
AU2002346065A8 (en)	2007-12-20	Methods of using electron active compounds for managing conditions afflicting mammals
AU1924301A (en)	2001-06-04	Method for operating an integrated point of presence server network
EP1638137A4 (de)	2010-12-01	Elektronenstrahl-mikroverarbeitungsverfahren
ATE355296T1 (de)	2006-03-15	Verfahren zur herstellung von (e,z) 3-(2- aminoethoxyimino)-androstane-6,17-dione und analoge
NO20073276L (no)	2007-09-04	Metode for fremstilling av aminoetoksybenzylalkoholer
WO2007035478A3 (en)	2007-11-22	Niacin receptor agonists, compositions containing such compounds and methods of treatment
MX2007002833A (es)	2007-07-09	Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios.
AU2003257051A1 (en)	2004-02-25	Composition and method for lowering cholesterol

Legal Events

Date	Code	Title	Description
2014-07-29	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 11A ANUIDADE.
2016-03-29	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.